These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16506431)

  • 1. Targeted magnetic resonance imaging contrast agents.
    Caruthers SD; Winter PM; Wickline SA; Lanza GM
    Methods Mol Med; 2006; 124():387-400. PubMed ID: 16506431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted contrast agents for magnetic resonance imaging and ultrasound.
    Morawski AM; Lanza GA; Wickline SA
    Curr Opin Biotechnol; 2005 Feb; 16(1):89-92. PubMed ID: 15722020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy.
    Cyrus T; Winter PM; Caruthers SD; Wickline SA; Lanza GM
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):705-15. PubMed ID: 16076280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future directions in body magnetic resonance imaging.
    Hyslop WB; Semelka RC
    Top Magn Reson Imaging; 2005 Feb; 16(1):3-14. PubMed ID: 16314694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging of cell surface receptors using targeted contrast agents.
    Artemov D; Bhujwalla ZM; Bulte JW
    Curr Pharm Biotechnol; 2004 Dec; 5(6):485-94. PubMed ID: 15579038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery.
    Lanza GM; Winter P; Caruthers S; Schmeider A; Crowder K; Morawski A; Zhang H; Scott MJ; Wickline SA
    Curr Pharm Biotechnol; 2004 Dec; 5(6):495-507. PubMed ID: 15579039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of image heterogeneity using 2D Minkowski functionals increases the sensitivity of detection of a targeted MRI contrast agent.
    Canuto HC; McLachlan C; Kettunen MI; Velic M; Krishnan AS; Neves AA; de Backer M; Hu DE; Hobson MP; Brindle KM
    Magn Reson Med; 2009 May; 61(5):1218-24. PubMed ID: 19253374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging.
    Neubauer AM; Sim H; Winter PM; Caruthers SD; Williams TA; Robertson JD; Sept D; Lanza GM; Wickline SA
    Magn Reson Med; 2008 Dec; 60(6):1353-61. PubMed ID: 19025903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits.
    Zheng J; Ochoa E; Misselwitz B; Yang D; El Naqa I; Woodard PK; Abendschein D
    Invest Radiol; 2008 Jan; 43(1):49-55. PubMed ID: 18097277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of digital waveforms using thermodynamic analogs: detection of contrast-targeted tissue in vivo.
    Hughes MS; Marsh JN; Zhang H; Woodson AK; Allen JS; Lacy EK; Carradine C; Lanza GM; Wickline SA
    IEEE Trans Ultrason Ferroelectr Freq Control; 2006 Sep; 53(9):1609-16. PubMed ID: 16964911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on ADC reductions in postcontrast breast tumors.
    Ramadan S; Mulkern RV
    J Magn Reson Imaging; 2010 Jan; 31(1):262; author reply 263-4. PubMed ID: 20027600
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances in magnetic resonance (2005).
    Runge VM
    Invest Radiol; 2005 Dec; 40(12):798-802. PubMed ID: 16304484
    [No Abstract]   [Full Text] [Related]  

  • 13. Spin echo magnetic resonance imaging.
    Jung BA; Weigel M
    J Magn Reson Imaging; 2013 Apr; 37(4):805-17. PubMed ID: 23526758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo target-specific delivery of macromolecular agents with MR-guided focused ultrasound.
    Bednarski MD; Lee JW; Callstrom MR; Li KC
    Radiology; 1997 Jul; 204(1):263-8. PubMed ID: 9205257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
    Al-Jamal WT; Kostarelos K
    Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.
    Kaneda MM; Caruthers S; Lanza GM; Wickline SA
    Ann Biomed Eng; 2009 Oct; 37(10):1922-33. PubMed ID: 19184435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superparamagnetic nanoparticles - a tool for early diagnostics.
    Hofmann-Amtenbrink M; Hofmann H; Montet X
    Swiss Med Wkly; 2010; 140():w13081. PubMed ID: 20853192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in magnetic resonance (2008).
    Runge VM
    Invest Radiol; 2008 Dec; 43(12):893-8. PubMed ID: 19002061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging with targeted contrast agents.
    Makowski MR; Wiethoff AJ; Jansen CH; Botnar RM
    Top Magn Reson Imaging; 2009 Aug; 20(4):247-59. PubMed ID: 20805735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of multimodality imaging in the diagnosis and treatment of hypertrophic cardiomyopathy.
    Koss E; Garcia MJ
    Semin Roentgenol; 2012 Jul; 47(3):253-61. PubMed ID: 22657115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.